Proteinosis alveolar. Respuesta al tratamiento con factor estimulante de colonias de granulocitos y macrófagos por vía inhalada
Authors:
- José Antonio Rodríguez PortalJPJosé Antonio Rodríguez Portal
- Eulogio Rodríguez BecerraEBEulogio Rodríguez Becerra
- Antonio Sánchez GarridoAGAntonio Sánchez Garrido
- 1 March 2009
- journal article
- case report
- Published by Elsevier in Archivos de Bronconeumología
- Vol. 45 (3) , 150-152
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- GM-CSF Autoantibodies and Neutrophil Dysfunction in Pulmonary Alveolar ProteinosisNew England Journal of Medicine, 2007
- Pulmonary Alveolar ProteinosisNew England Journal of Medicine, 2003
- Pulmonary Alveolar Proteinosis: Progress in the First 44 YearsAmerican Journal of Respiratory and Critical Care Medicine, 2002
- Eficacia terapéutica del GM-CSF en la proteinosis alveolar pulmonarArchivos de Bronconeumología, 2002
- CT Features of Pulmonary Alveolar ProteinosisAmerican Journal of Roentgenology, 2001
- Detection of Granulocyte–Macrophage Colony-Stimulating Factor in Patients with Pulmonary Alveolar ProteinosisAmerican Journal of Respiratory and Critical Care Medicine, 2000
- Normativa sobre la utilización de fármacos inhaladosArchivos de Bronconeumología, 2000
- Idiopathic Pulmonary Alveolar Proteinosis as an Autoimmune Disease with Neutralizing Antibody against Granulocyte/Macrophage Colony-Stimulating FactorJournal of Experimental Medicine, 1999
- Human pulmonary alveolar proteinosis associated with a defect in GM-CSF/IL-3/IL-5 receptor common beta chain expression.Journal of Clinical Investigation, 1997
- Evaluation of Clinical Methods for Rating DyspneaChest, 1988